Primary Site >> Liver Cancer
Gene >> CPQ
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule. PMID: 15996019 |
Ref: An enediyne-energized single-domain antibody-containing fusion protein shows potent antitumor activity. PMID: 17159599 Ref: Generation and antitumor effects of an engineered and energized fusion protein VL-LDP-AE composed of single-domain antibody and lidamycin. PMID: 17653664 |
Ref: Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer. PMID: 22651685 Ref: Antitumor activities of dFv-LDP-AE: An enediyne-energized fusion protein targeting tumor-associated antigen gelatinases. PMID: 22797730 Ref: A cell penetrating peptide-integrated and enediyne-energized fusion protein shows potent antitumor activity. PMID: 22982402 |
Ref: An NGR-integrated and enediyne-energized apoprotein shows CD13-targeting antitumor activity. PMID: 23206754 |
Ref: A Gelatinases-targeting scFv-based Fusion Protein Shows Enhanced Antitumour Activity with Endostar against Hepatoma. PMID: 25615234 |
Ref: Plasma glutamate carboxypeptidase is a negative regulator in liver cancer metastasis. PMID: 27806330 |
Ref: A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis. PMID: 27991698 |